All In Biotech

Free tool

FAERS Monitor: Prempro

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020527 or its brand name (Prempro, Estrogens, Conjugated, Medroxyprogesterone Acetate). Reports on generic versions are filed under their own applications.

Reports

23,488

Serious

19,848

85% of reports

Hospitalization

2,759

Death reported

648

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • breast cancer7,889
  • breast cancer female5,791
  • breast cancer metastatic1,505
  • drug ineffective738
  • cerebrovascular accident502
  • depression478
  • headache426
  • anxiety418
  • nausea414
  • deep vein thrombosis397
  • fatigue395
  • hot flush388
  • pain383
  • insomnia380
  • myocardial infarction378

Reports by year received

View as table
YearReports
20041,602
20051,529
20061,384
2007949
20081,913
20094,410
20105,905
20111,202
2012754
2013487
2014363
2015389
2016399
2017311
2018237
2019322
2020371
2021224
2022259
2023157
2024132
2025119
202668

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,030,671 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
breast cancer femaleSignal5,791247.5241.11,115,140
breast cancer metastaticSignal1,505145.9138.3186,153
breast cancerSignal7,88982.781.1585,463
deep vein thrombosisSignal3975.55.01,452
hot flushSignal3884.64.21,098
cerebrovascular accidentSignal5022.72.4520
myocardial infarction3781.91.8173
depression4781.91.7199
anxiety4181.31.232
insomnia3801.31.223
headache4260.60.6110
pain3830.60.5138
drug ineffective7380.50.5390
nausea4140.50.4259
fatigue3950.50.4269

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.